Published Paper Details:

Alzheimer's disease also called as senile dementia.It is a progressive disease that destroys memory & other important mental functions. In this, Brain cell connections & the cells themselves degenerate & die eventually destroying Memory & other important Mental Functions. As the disease advances, symptoms can include problems with language, disorientation, mood swings, self neglect & behavioural issues, etc There is a substantial need for new therapies that offer improved symptomatic benefit & disease- slowing capabilities.The aged population is growing globally, creating an urgent need for more promising therapies for this debilitating disease. In these there are various drugs are developed For the treatment of Alzheimer's Disease e.g. Lecanemab.Lecanemab is an amyloid beta- targeting antibody used to treat Alzheimer's Disease. Here we cover the mechanism of action of targeted therapies & therapeutical agents/drugs to re-think drug development strategies & development of targeted therapies for Alzheimer's disease. & also directions for future studies.